@lionbio.com
Learn about our investigational tumor infiltrating lymphocyte (TIL) therapy and peripheral blood lymphocyte (PBL) therapy.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
Icon
JPEG
About
Description
Iovance Biotherapeutics is a pioneering brand that offers a transformational approach to treating cancer. They harness the power of the human immune system to recognize and attack diverse cancer cells in each patient. Their investigational TIL (tumor infiltrating lymphocyte) therapy focuses on naturally occurring immune cells that fight cancer.
These TIL cells are collected and grown outside the body, then administered back to the patient as a one-time treatment. Iovance TIL therapy deploys billions of personalized, patient-specific TIL to recognize and target various cancer cells. They are currently investigating TIL monotherapy and combination therapies in clinical studies for advanced solid tumor cancers like melanoma, non-small cell lung cancer, cervical cancer, and head and neck cancer.
In addition, Iovance offers a PBL (peripheral blood lymphocyte) therapy platform for blood cancers. Their T-cell-based immunotherapy technology platforms are focused on leveraging patient-specific cells to recognize and attack unique cancer cells. Learn more about their TIL therapy, clinical trials, and cell therapy manufacturing facility, the iCTC.
Please note that their therapies are investigational and have not been approved by regulatory agencies
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories